ポストバイオティクス 凝固と生存を抑制する
Qinglian Hua1, Jinpeng Hu1, Xiaowen Zhang2
1College of Food Science and Engineering, Ocean University of China, Qingdao 266000, China.
Journal of agricultural and food chemistry
|August 20, 2025
まとめ
Lactobacillus rhamnosus MN45からのポストバイオティクスは,ヘリコバクター・パイロリとの強い凝結を示し,その有害な活動を抑制する. この発見は H. pylori 感染症と抗生物質耐性に対する新しい戦略を提供します.
科学分野:
- 微生物学
- 胃腸内科
- バイオテクノロジー
背景:
- ヘリコバクター・パイロリ感染は胃疾患の主な原因で,抗生物質耐性の上昇によって複雑化します.
- ポストバイオティクスは H. pylori 管理のための安全な代替手段として出現していますが,スクリーニング方法は未開発です.
研究 の 目的:
- H. pylori 抗生物質を特定するための新しいスクリーニング戦略を開発し,適用する.
- 有望なポストバイオティクスと H. pylori の間の凝縮メカニズムを調査する.
主な方法:
- 人工胃汁とAGS細胞モデルをスクリーニングに使用した.
- 視覚化のためにレーザーコンフォカルとスキャニング電子顕微鏡を使用した.
- Lactobacillus rhamnosus MN45の比較ゲノム分析を実施した.
主要な成果:
- Lactobacillus rhamnosus MN45はH. pyloriとの強力な凝結を示した.
- MN45はH. pylori尿素酵素の活性,ウイルス性因子の発現,および炎症反応を著しく低下させた.
- 凝縮効果は酸性条件下では安定し,時間とともに増加した.
結論:
- Lactobacillus rhamnosus MN45は,抗H. pyloriのポストバイオティック療法のための有望な候補である.
- この研究は,COG1396増幅を含む新しいポストバイオティック媒介の凝集メカニズムを明らかにしています.
- この研究は,H. pyloriに対する新しい戦略を開発するための基盤を提供します.
関連する概念動画
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
546
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
546
01:13Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
525
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
525
01:24Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
563
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
563
01:28Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
569
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
569
01:22Pathophysiology of Peptic Ulcer Disease: Injurious Factors
701
Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
701
01:28Peptic Ulcer Disease II: Pathophysiology
838
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
838